111 related articles for article (PubMed ID: 19786353)
1. Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancers.
Martini E; Salvicchi A; Ghelardini C; Manetti D; Dei S; Guandalini L; Martelli C; Melchiorre M; Cellai C; Scapecchi S; Teodori E; Romanelli MN
Bioorg Med Chem; 2009 Nov; 17(21):7606-14. PubMed ID: 19786353
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators.
Martini E; Norcini M; Ghelardini C; Manetti D; Dei S; Guandalini L; Melchiorre M; Pagella S; Scapecchi S; Teodori E; Romanelli MN
Bioorg Med Chem; 2008 Dec; 16(23):10034-42. PubMed ID: 18954993
[TBL] [Abstract][Full Text] [Related]
3. Influence of ring size on the cognition-enhancing activity of DM235 and MN19, two potent nootropic drugs.
Guandalini L; Martini E; Di Cesare Mannelli L; Dei S; Manetti D; Scapecchi S; Teodori E; Ghelardini C; Romanelli MN
Bioorg Med Chem Lett; 2012 Mar; 22(5):1936-9. PubMed ID: 22325944
[TBL] [Abstract][Full Text] [Related]
4. Substituted piperazines as nootropic agents: 2- or 3-phenyl derivatives structurally related to the cognition-enhancer DM235.
Guandalini L; Martino MV; Di Cesare Mannelli L; Bartolucci G; Melani F; Malik R; Dei S; Floriddia E; Manetti D; Orlandi F; Teodori E; Ghelardini C; Romanelli MN
Bioorg Med Chem Lett; 2015 Apr; 25(8):1700-1704. PubMed ID: 25813160
[TBL] [Abstract][Full Text] [Related]
5. Piperazines as nootropic agents: New derivatives of the potent cognition-enhancer DM235 carrying hydrophilic substituents.
Martino MV; Guandalini L; Di Cesare Mannelli L; Menicatti M; Bartolucci G; Dei S; Manetti D; Teodori E; Ghelardini C; Romanelli MN
Bioorg Med Chem; 2017 Mar; 25(6):1795-1803. PubMed ID: 28238510
[TBL] [Abstract][Full Text] [Related]
6. DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer.
Ghelardini C; Galeotti N; Gualtieri F; Romanelli MN; Bucherelli C; Baldi E; Bartolini A
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):419-26. PubMed ID: 12070754
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and preliminary pharmacological evaluation of new piperidine and piperazine derivatives as cognition-enhancers.
Martini E; Ghelardini C; Dei S; Guandalini L; Manetti D; Melchiorre M; Norcini M; Scapecchi S; Teodori E; Romanelli MN
Bioorg Med Chem; 2008 Feb; 16(3):1431-43. PubMed ID: 17981042
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship studies on unifiram (DM232) and sunifiram (DM235), two novel and potent cognition enhancing drugs.
Scapecchi S; Martini E; Manetti D; Ghelardini C; Martelli C; Dei S; Galeotti N; Guandalini L; Novella Romanelli M; Teodori E
Bioorg Med Chem; 2004 Jan; 12(1):71-85. PubMed ID: 14697772
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition enhancers.
Romanelli MN; Galeotti N; Ghelardini C; Manetti D; Martini E; Gualtieri F
CNS Drug Rev; 2006; 12(1):39-52. PubMed ID: 16834757
[TBL] [Abstract][Full Text] [Related]
10. Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity.
Manetti D; Ghelardini C; Bartolini A; Dei S; Galeotti N; Gualtieri F; Romanelli MN; Teodori E
J Med Chem; 2000 Nov; 43(23):4499-507. PubMed ID: 11087574
[TBL] [Abstract][Full Text] [Related]
11. Enantioselective synthesis and preliminary pharmacological evaluation of the enantiomers of unifiram (DM232), a potent cognition-enhancing agent.
Martini E; Ghelardini C; Bertucci C; Dei S; Gualtieri F; Guandalini L; Manetti D; Scapecchi S; Teodori E; Romanelli MN
Med Chem; 2005 Sep; 1(5):473-80. PubMed ID: 16787332
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and preliminary pharmacological evaluation of 1, 4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic agents.
Manetti D; Ghelardini C; Bartolini A; Bellucci C; Dei S; Galeotti N; Gualtieri F; Romanelli MN; Scapecchi S; Teodori E
J Med Chem; 2000 May; 43(10):1969-74. PubMed ID: 10821709
[TBL] [Abstract][Full Text] [Related]
13. Unifi nootropics from the lab to the web: a story of academic (and industrial) shortcomings.
Gualtieri F
J Enzyme Inhib Med Chem; 2016; 31(2):187-94. PubMed ID: 25831025
[TBL] [Abstract][Full Text] [Related]
14. AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram).
Galeotti N; Ghelardini C; Pittaluga A; Pugliese AM; Bartolini A; Manetti D; Romanelli MN; Gualtieri F
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):538-45. PubMed ID: 14600801
[TBL] [Abstract][Full Text] [Related]
15. 2-pyrrolidinone moiety is not critical for the cognition-enhancing activity of piracetam-like drugs.
Scapecchi S; Martelli C; Ghelardini C; Guandalini L; Martini E; Gualtieri F
Farmaco; 2003 Sep; 58(9):715-22. PubMed ID: 13679165
[TBL] [Abstract][Full Text] [Related]
16. 4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs.
Manetti D; Martini E; Ghelardini C; Dei S; Galeotti N; Guandalini L; Romanelli MN; Scapecchi S; Teodori E; Bartolini A; Gualtieri F
Bioorg Med Chem Lett; 2003 Jul; 13(14):2303-6. PubMed ID: 12824022
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis and Molecular Docking Studies of New Potential Piperazine Derivatives as Cognition Enhancers.
Danta CC; Piplani P
Cent Nerv Syst Agents Med Chem; 2017; 17(2):157-170. PubMed ID: 27758699
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and nootropic activity of some 2,3-dihydro-1H-isoindol-1-one derivatives structurally related with piracetam.
Reyes A; Huerta L; Alfaro M; Navarrete A
Chem Biodivers; 2010 Nov; 7(11):2718-26. PubMed ID: 21072771
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of some acridine-piperazine hybrids for the improvement of cognitive dysfunction.
Sharma A; Piplani P
Chem Biol Drug Des; 2017 Nov; 90(5):926-935. PubMed ID: 28544619
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 3,7-diazabicyclo[4.3.0]nonan-8-ones as potential nootropic and analgesic drugs.
Martini E; Di Cesare Mannelli L; Bartolucci G; Bertucci C; Dei S; Ghelardini C; Guandalini L; Manetti D; Scapecchi S; Teodori E; Romanelli MN
J Med Chem; 2011 Apr; 54(7):2512-6. PubMed ID: 21381762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
